BioCentury
ARTICLE | Clinical News

BC-819: Pilot trial data

October 12, 2015 7:00 AM UTC

A pilot trial in 38 intermediate- and high-risk bladder cancer patients showed that an alternating treatment regimen with BC-819 followed by bacillus Calmette-Guerin (BCG) once or twice weekly was saf...